GT Biopharma, Inc. Business Operations Contracts & Agreements
13 Contracts & Agreements
- Advisory Agreements (1 contract)
- Indemnification Agreements (1)
- Services Agreements (7)
- Settlement Agreements (4)
- Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc (Filed With SEC on October 31, 2022)
- Board Service Agreement with Michael Breen dated November 11, 2020 (Filed With SEC on May 16, 2022)
- Board Service Agreement with Rajesh Shrotriya, dated January 12, 2021 (Filed With SEC on February 8, 2021)
- Board Service Agreement with Michael Breen, dated January 12, 2021 (Filed With SEC on February 8, 2021)
- Settlement Agreement, dated as of November 9, 2020, by and among Adam Kasower, East Ventures, Inc., A British Virgin Islands company, SV Booth Investments III, LLC, a Delaware... (Filed With SEC on November 13, 2020)
- Board Service Agreement with Bruce Wendel, dated November 11, 2020 (Filed With SEC on November 13, 2020)
- Board Service Agreement with Greg Berk, dated November 11, 2020 (Filed With SEC on November 13, 2020)
- Master Services Agreement (Filed With SEC on October 6, 2020)
- Settlement Agreement, dated as of June 19, 2020, among GT Biopharma, Inc., Empery Asset Master Ltd., Empery Tax Efficient, LP and Empery Tax Efficient II, LP, Anthony Cataldo and... (Filed With SEC on June 19, 2020)
- INDEMNIFICATION AGREEMENT (Filed With SEC on July 5, 2018)
- SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE (Filed With SEC on August 20, 2012)
- AMENDMENT TO ADVISORY AGREEMENT (Filed With SEC on October 16, 2007)
- MUTUAL SERVICES AGREEMENT (Filed With SEC on June 29, 2006)
